slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 66,691-66,720
Pages 3,679
Rows per page 30
Component
66,691-66,720 of 110,355
04
The slide uses a side-by-side comparison framework to highlight two major therapeutic areas.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
07
The slide uses a mix of epidemiological data and commercial benchmarks to validate the market size.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Market Size1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a 2x2 matrix structure to compare two patients across two time points.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
13
Includes PET scan imagery showing metabolic response in a patient.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
16
The slide outlines a two-phase clinical trial structure and the specific patient progression timeline being measured.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a Kaplan-Meier survival plot to illustrate therapeutic efficacy.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents two charts: a line chart showing tumor progression over time and a bar chart showing tumor intensity at week 4.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a histology image to visually demonstrate negative TUSC2 expression in SCLC.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
26
The slide uses a pie chart to illustrate the market split between Type 1 and Type 2 diabetes.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
27
The slide uses a two-column layout to contrast disease burden metrics with market size projections.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
28
The slide uses a two-column layout to present various medical conditions caused by diabetes, supported by statistical data points.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
29
Includes a scientific diagram illustrating the alpha-to-beta cell reprogramming process.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
38
The slide uses a split-screen layout with a blue left panel for the vision statement and a white right panel for key strategic pillars.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Loop · Why Now1 hit
32
Includes a line chart showing blood glucose over time and a bar chart showing beta cell mass comparison.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
33
The charts track insulin/carb ratios over time relative to a viral infusion event.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
43
The slide uses a split-screen layout to contrast the high-level vision (left) with specific strategic pillars (right).Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
04
Includes a bar chart of clinical trials by mechanism, a pie chart of organ distribution, and a stacked bar chart of trials over time.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
11
The slide uses a process diagram to show disease progression and three columns to define the specific conditions.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
16
The slide outlines a 42-day study timeline with a 28-day treatment period.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
29
Includes specific stopping rules for futility based on Disease Control Rate (DCR).Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
03
The slide uses a structured layout to present high-level corporate KPIs followed by segment-specific bulleted performance summaries.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations Beat · ProblemLoop · Logic Chain1 hit
04
The chart combines bar, line, and area elements to show three distinct financial metrics over time.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations Beat · ProblemLoop · Logic Chain1 hit
08
Includes a waterfall chart for rate sensitivity, two pie charts for asset composition, and a line chart for historical interest rate trends.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
10
Includes a waterfall-style bridge for Q3 2021 to Q3 2022 expenses and a detailed table of segment-specific KPIs.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
13
The slide presents a stacked bar chart of deposit mix over five quarters, a table of key cost statistics, and a pie chart of interest-bearing deposits by type.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
16
Efficiency Ratio is calculated as noninterest expense divided by the sum of net interest income and noninterest income.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations 1 hit
17
Includes a footnote explaining the calculation of Gain on Sale.Hilltop Holdings | Results Presentation Deck | 19 slides · Hilltop Holdings
Conference presentation Investor relations 1 hit
07
3Q22 results; revenue growth rates @CCIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
08
3Q22 results; revenue growth rates @CCIBM | Results Presentation Deck | 29 slides · IBM
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit